Bank Of America Corp Evogene Ltd. Transaction History

Bank Of America Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.61 - $0.82 $3,239 - $4,355	5,311 Added 494.51%	6,385 $4,000
Q1 2024 May 15, 2024	SELL	$0.7 - $0.98 $191 - $268	-274 Reduced 20.33%	1,074 $0
Q4 2023 Feb 14, 2024	SELL	$0.47 - $0.88 $145 - $272	-310 Reduced 18.7%	1,348 $1,000
Q2 2023 Aug 14, 2023	SELL	$0.56 - $1.2 $12,391 - $26,552	-22,127 Reduced 93.03%	1,658 $1,000
Q1 2023 May 12, 2023	SELL	$0.59 - $0.86 $69,769 - $101,698	-118,254 Reduced 83.25%	23,785 $14,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $8.65 $4,242 - $50,273	5,812 Added 4.27%	142,039 $118,000
Q2 2022 Aug 12, 2022	SELL	$0.75 - $1.33 $51,220 - $90,831	-68,294 Reduced 33.39%	136,227 $104,000
Q1 2022 May 16, 2022	BUY	$1.09 - $1.83 $73,975 - $124,196	67,867 Added 49.66%	204,521 $265,000
Q4 2021 Feb 08, 2022	BUY	$1.63 - $2.83 $220,424 - $382,700	135,230 Added 9496.49%	136,654 $224,000
Q3 2021 Nov 15, 2021	SELL	$2.45 - $3.45 $8,903 - $12,537	-3,634 Reduced 71.85%	1,424 $3,000
Q2 2021 Sep 13, 2021	BUY	$3.3 - $5.02 $16,691 - $25,391	5,058 New	5,058 $17,000

117K

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $69.6M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.